Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryce Kerlin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Critical Care Medicine|May 1, 2004
Factor V Leiden polymorphism modifies sepsis outcome: evidence from animal studiesHartmut Weiler, Bryce Kerlin, Mary C Lytle
Pediatric Blood & Cancer|June 18, 2009
Prevalence of abnormal bone density of pediatric patients prior to blood or marrow transplantKathryn J Klopfenstein, Julie Clayton, Robin Rosselet, et al.
Seminars in Thrombosis and Hemostasis|August 25, 2016
Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and SuccessesManuel Carcao, Katsuyuki Fukutake, Aida Inbal, et al.
Stroke|November 23, 2007
The cost of pediatric stroke care and rehabilitationWarren Lo, Khaled Zamel, Kavita Ponnappa, et al.
Blood|November 15, 2003
Cause-effect relation between hyperfibrinogenemia and vascular diseaseBryce Kerlin, Brian C Cooley, Berend H Isermann, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 17, 2015
Reference Range of Platelet Delta Granules in the Pediatric Age Group: An Ultrastructural Study of Platelet Whole Mount Preparations from Healthy VolunteersVictoria Sorokin, Razan Alkhoury, Sura Al-Rawabdeh, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2005
Temozolomide and radiation for aggressive pediatric central nervous system malignanciesKenneth C Loh, Jennifer Willert, Hal Meltzer, et al.
Clinical Kidney Journal|May 13, 2025
Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohortBlanca Tarragón, Heedeok Han, Mariela Navarro-Torres, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Critical Care Medicine|May 1, 2004
Factor V Leiden polymorphism modifies sepsis outcome: evidence from animal studiesHartmut Weiler, Bryce Kerlin, Mary C Lytle
Pediatric Blood & Cancer|June 18, 2009
Prevalence of abnormal bone density of pediatric patients prior to blood or marrow transplantKathryn J Klopfenstein, Julie Clayton, Robin Rosselet, et al.
Seminars in Thrombosis and Hemostasis|August 25, 2016
Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and SuccessesManuel Carcao, Katsuyuki Fukutake, Aida Inbal, et al.
Stroke|November 23, 2007
The cost of pediatric stroke care and rehabilitationWarren Lo, Khaled Zamel, Kavita Ponnappa, et al.
Blood|November 15, 2003
Cause-effect relation between hyperfibrinogenemia and vascular diseaseBryce Kerlin, Brian C Cooley, Berend H Isermann, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 17, 2015
Reference Range of Platelet Delta Granules in the Pediatric Age Group: An Ultrastructural Study of Platelet Whole Mount Preparations from Healthy VolunteersVictoria Sorokin, Razan Alkhoury, Sura Al-Rawabdeh, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2005
Temozolomide and radiation for aggressive pediatric central nervous system malignanciesKenneth C Loh, Jennifer Willert, Hal Meltzer, et al.
Clinical Kidney Journal|May 13, 2025
Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohortBlanca Tarragón, Heedeok Han, Mariela Navarro-Torres, et al.
Pageof 1